345 related articles for article (PubMed ID: 36235023)
21. Fresh platinum complexes with promising antitumor activity.
Wang X
Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
[TBL] [Abstract][Full Text] [Related]
22. Ruthenium(II) and Platinum(II) Complexes with Biologically Active Aminoflavone Ligands Exhibit In Vitro Anticancer Activity.
Fabijańska M; Kasprzak MM; Ochocki J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299199
[TBL] [Abstract][Full Text] [Related]
23. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
24. Multi-Target Metal-Based Anticancer Agents.
Chen ZF; Orvig C; Liang H
Curr Top Med Chem; 2017 Nov; 17(28):3131-3145. PubMed ID: 28982336
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapeutic Drugs and Plasma Proteins: Exploring New Dimensions.
Zia MK; Siddiqui T; Ali SS; Rehman AA; Ahsan H; Khan FH
Curr Protein Pept Sci; 2018; 19(10):937-947. PubMed ID: 28969563
[TBL] [Abstract][Full Text] [Related]
27. Linking the future of anticancer metal-complexes to the therapy of tumour metastases.
Bergamo A; Sava G
Chem Soc Rev; 2015 Dec; 44(24):8818-35. PubMed ID: 25812154
[TBL] [Abstract][Full Text] [Related]
28. Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy.
Liu J; Lai H; Xiong Z; Chen B; Chen T
Chem Commun (Camb); 2019 Aug; 55(67):9904-9914. PubMed ID: 31360938
[TBL] [Abstract][Full Text] [Related]
29. Anticancer metallotherapeutics in preclinical development.
Kaluderović GN; Paschke R
Curr Med Chem; 2011; 18(31):4738-52. PubMed ID: 21919843
[TBL] [Abstract][Full Text] [Related]
30. An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy.
Katarzyna M; Anna S; Zielinska-Blizniewska H; Ireneusz M
Mini Rev Med Chem; 2018; 18(16):1373-1381. PubMed ID: 29692246
[TBL] [Abstract][Full Text] [Related]
31. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy.
Babak MV; Ang WH
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in multinuclear complexes as potential anticancer and DNA binding agents.
Wang K; Gao E
Anticancer Agents Med Chem; 2014 Jan; 14(1):147-69. PubMed ID: 23869783
[TBL] [Abstract][Full Text] [Related]
33. Progresses in TCM metal-based antitumour agents.
Chen ZF; Liang H
Anticancer Agents Med Chem; 2010 Jun; 10(5):412-23. PubMed ID: 20545619
[TBL] [Abstract][Full Text] [Related]
34. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases.
Lu Y; Ma X; Chang X; Liang Z; Lv L; Shan M; Lu Q; Wen Z; Gust R; Liu W
Chem Soc Rev; 2022 Jul; 51(13):5518-5556. PubMed ID: 35699475
[TBL] [Abstract][Full Text] [Related]
35. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
36. Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.
Morais TS; Valente A; Tomaz AI; Marques F; Garcia MH
Future Med Chem; 2016 Apr; 8(5):527-44. PubMed ID: 27096164
[TBL] [Abstract][Full Text] [Related]
37. Phosphoroorganic Metal Complexes in Therapeutics.
Demkowicz S; Kozak W; Daśko M; Rachon J
Mini Rev Med Chem; 2016; 16(17):1359-1373. PubMed ID: 27145849
[TBL] [Abstract][Full Text] [Related]
38. Stimuli-Responsive Therapeutic Metallodrugs.
Wang X; Wang X; Jin S; Muhammad N; Guo Z
Chem Rev; 2019 Jan; 119(2):1138-1192. PubMed ID: 30299085
[TBL] [Abstract][Full Text] [Related]
39. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
[TBL] [Abstract][Full Text] [Related]
40. Multi-Targeted Anticancer Agents.
Zheng W; Zhao Y; Luo Q; Zhang Y; Wu K; Wang F
Curr Top Med Chem; 2017 Nov; 17(28):3084-3098. PubMed ID: 28685693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
